4//SEC Filing
Lochner Daniel 4
Accession 0001209191-21-062476
CIK 0001720725other
Filed
Nov 1, 8:00 PM ET
Accepted
Nov 2, 5:49 PM ET
Size
7.3 KB
Accession
0001209191-21-062476
Insider Transaction Report
Form 4
Lochner Daniel
Chief Financial Officer
Transactions
- Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-11-01−8,590→ 161,251 totalExercise: $11.51Exp: 2029-07-25→ Common Stock (8,590 underlying) - Exercise/Conversion
Common Stock
2021-11-01$11.51/sh+8,590$98,871→ 58,221 total
Footnotes (1)
- [F1]The Option was granted on July 25, 2019 under the Oyster Point Pharma, Inc. 2016 Equity Incentive Plan. One quarter of the total number of shares subject to the option vested on July 22, 2020, and one forty-eighth of the total number of shares continue to vest monthly thereafter, subject to continued service to the Issuer through each such vesting date. The award is subject to vesting acceleration under certain circumstances.
Documents
Issuer
Oyster Point Pharma, Inc.
CIK 0001720725
Entity typeother
Related Parties
1- filerCIK 0001791187
Filing Metadata
- Form type
- 4
- Filed
- Nov 1, 8:00 PM ET
- Accepted
- Nov 2, 5:49 PM ET
- Size
- 7.3 KB